Untargeted metabolomics-based exploration of potential metabolic biomarkers for subclinical atherosclerosis in metabolic-associated fatty liver disease
湖南省自然科学基金(2024JJ5543;2024JJ5521);长沙市自然科学基金(kq2403048;kq2208351┫。This work was supported by the Natural Science Foundation of Hunan Province ┣2024JJ5543;2024JJ5521);the Natural Science Foundation of Changsha(kq2403048;kq2208351);China.开放获取(Open access):本文遵循知识共享许可协议,允许第三方用户按照署名-非商业性使用-禁止演绎4.0(CC BY-NC-ND 4.0┫的方式;在任何媒介以任何形式复制、传播本作品┣https://creativecommons.org/licenses/by-nc-nd/4.0/)
WANG Yaqin, YUAN Ting, LIU Lei, SU Zhuolin, WAN Linlin, WANG Changfa, ZHU Xiaoling, HU Zhongyang. Untargeted metabolomics-based exploration of potential metabolic biomarkers for subclinical atherosclerosis in metabolic-associated fatty liver disease[J]. Journal of Central South University. Medical Science, 2026, 51(4): 692-703.
WANG Yaqin, YUAN Ting, LIU Lei, SU Zhuolin, WAN Linlin, WANG Changfa, ZHU Xiaoling, HU Zhongyang. Untargeted metabolomics-based exploration of potential metabolic biomarkers for subclinical atherosclerosis in metabolic-associated fatty liver disease[J]. Journal of Central South University. Medical Science, 2026, 51(4): 692-703.DOI:10.11817/j.issn.1672-7347.2026.260024.